Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMBINATION ALKYLATING-AGENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Baynes, RD; Dansey, RD; Klein, JL; Hamm, C; Campbell, M; Abella, E; Peters, WP
      High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: Past or future?

      SEMINARS IN ONCOLOGY
    3. Miller, KD; Sledge, GW
      High-dose chemotherapy in breast cancer - The perils of history uncontrolled

      MEDSCAPE WOMENS HEALTH
    4. Nieto, Y; Champlin, RE; Wingard, JR; Vredenburgh, JJ; Elias, AD; Richardson, PR; Glaspy, J; Jones, RB; Stiff, PJ; Bearman, SI; Cagnoni, PJ; McSweeney, PA; LeMaistre, CF; Pecora, AL; Shpall, EJ
      Status of high-dose chemotherapy for breast cancer: A review

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    5. Nieto, Y; Cagnoni, PJ; Bearman, SI; Shpall, EJ; Matthes, S; Jones, RB
      Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU(STAMP-I) for breast cancer

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    6. Baynes, RD; Dansey, RD; Klein, JL; Karanes, C; Cassells, L; Abella, E; Wei, WZ; Galy, A; Du, W; Wood, G; Peters, WP
      High-dose chemotherapy and autologous stem cell transplantation for breastcancer

      CANCER INVESTIGATION
    7. Patnaik, A; MacKinnon, A; Goss, P; Nagy, T; Stewart, K; Keating, A; Crump, M
      Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses ofcarboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    8. Frei, E; Ara, G; Teicher, B; Bunnell, C; Richardson, P; Wheeler, C; Tew, K; Elias, A
      Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. LAZARUS HM
      HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION IN BREAST-CANCER - CURRENT STATUS AND FUTURE-DIRECTIONS

      Cancer investigation
    10. FISHER DC; VREDENBURGH JJ; PETROS WP; HUSSEIN A; BERRY DA; ELKORDY M; RUBIN P; GILBERT CJ; PETERS WP
      REDUCED MORTALITY FOLLOWING BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER WITH THE ADDITION OF PERIPHERAL-BLOOD PROGENITOR CELLS IS DUE TO A MARKED REDUCTION IN VENOOCCLUSIVE DISEASE OF THE LIVER

      Bone marrow transplantation
    11. BRUFMAN G; COLAJORI E; GHILEZAN N; LASSUS M; MARTONI A; PEREVODCHIKOVA N; TOSELLO C; VIARO D; ZIELINSKI C; KRAINER M; SALZER H; SCHULLER J; DITTRICH C; SCHEITHAUER W; ZAMAGNI C; AMBROSINI G; COLUCCI G; GENTILINI P; ZANIBONI A; PACINI P; BIANCO R; MUSTACCHI G; DAPRILE M; DEMATTEIS A; OLIVEIRA C; JORDAAN J; GUDGEON A; VANZYL J; RAKOWSKY E; INBAR M; RATH P; COHEN Y; SHANI A; FRIED G; HEGG R; NETO AB; BADER G; BRAGA RF; VITOC C; PUERTO VML; VALLE AE; SALAZAR JD; SANCHEZ JC; VILLELA GM; FOUNTZILAS G
      DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/

      Annals of oncology
    12. WOO MH; IPPOLITI C; BRUTON J; MEHRA R; CHAMPLIN R; PRZEPIORKA D
      HEADACHE, CIRCUMORAL PARESTHESIA, AND FACIAL FLUSHING ASSOCIATED WITHHIGH-DOSE CARMUSTINE INFUSION

      Bone marrow transplantation
    13. MCCAULEY DL
      HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL RESCUE FOR THE TREATMENT OF BREAST-CANCER

      American journal of health-system pharmacy
    14. BROCKSTEIN BE; WILLIAMS SF
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE FOR BREAST-CANCER - YESTERDAY, TODAY AND TOMORROW

      Stem cells
    15. CROWN J
      HIGH-DOSE CHEMOTHERAPY IN RESISTANT BREAST-CANCER

      Breast
    16. HUSSEIN AM; PETROS WP; ROSS M; VREDENBURGH JJ; AFFRONTI ML; JONES RB; SHPALL EJ; RUBIN P; ELKORDY M; GILBERT C; GUPTON C; EGORIN MJ; SOPER J; BERCHUCK A; CLARKEPEARSON D; BERRY DA; PETERS WP
      A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/

      Cancer chemotherapy and pharmacology
    17. HANSEN F; MOLLER P; SKOVSGAARD T
      PHASE-II STUDY OF 2ND-LINE TREATMENT WITH HIGH-DOSE CYCLOPHOSPHAMIDE IN RECURRENT METASTATIC BREAST-CANCER

      Cancer chemotherapy and pharmacology
    18. DILLMAN RO; BARTH NM; NAYAK SK; DELEON C; OCONNOR A; MORRELLI L
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN BREAST-CANCER

      Breast cancer research and treatment
    19. BEARMAN SI; SHPALL EJ; JONES RB; CAGNONI PJ; ROSS M
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOR METASTATIC AND HIGH-RISK PRIMARY BREAST-CANCER

      Seminars in oncology
    20. MEROUANI A; SHPALL EJ; JONES RB; ARCHER PG; SCHRIER RW
      RENAL-FUNCTION IN HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL SUPPORT TREATMENT FOR BREAST-CANCER

      Kidney international
    21. HONKOOP AH; PINEDO HM
      HIGH-DOSE CHEMOTHERAPY IN THE TREATMENT OF BREAST-CANCER

      International journal of oncology
    22. VREDENBURGH JJ; PETERS WP; ROSNER G; DESOMBRE K; JOHNSTON WW; KAMEL A; WU K; BAST RC
      DETECTION OF TUMOR-CELLS IN THE BONE-MARROW OF STAGE-IV BREAST-CANCERPATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY - THE ROLE OF INDUCTION CHEMOTHERAPY

      Bone marrow transplantation
    23. PETERS WP; ROSS M; VREDENBURGH JJ; HUSSEIN A; RUBIN P; DUKELOW K; CAVANAUGH C; BEAUVAIS R; KASPRZAK S
      THE USE OF INTENSIVE CLINIC SUPPORT TO PERMIT OUTPATIENT AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER

      Seminars in oncology
    24. DUNPHY FR; SPITZER G; FORNOFF JER; YAU JC; HUAN SD; DICKE KA; BUZDAR AU; HORTOBAGYI GN
      FACTORS PREDICTING LONG-TERM SURVIVAL FOR METASTATIC BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW SUPPORT

      Cancer
    25. PINEDO HM
      DOSE-EFFECT RELATIONSHIP IN BREAST-CANCER

      Annals of oncology
    26. MYERS SE; WILLIAMS SF
      ROLE OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL SUPPORT IN TREATMENT OF BREAST-CANCER

      Hematology/oncology clinics of North America
    27. PETERS WP; ROSS M; VREDENBURGH JJ; MEISENBERG B; MARKS LB; WINER E; KURTZBERG J; BAST RC; JONES R; SHPALL E; WU K; ROSNER G; GILBERT C; MATHIAS B; CONIGLIO D; PETROS W; HENDERSON IC; NORTON L; WEISS RB; BUDMAN D; HURD D
      HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER

      Journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 10:34:00